TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 826959

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Oxprenolol
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 31897949

Group type: EXPERIMENTAL
Intervention: Vitamin D3 2000 IU (50 μg) daily for 12 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 30303923

Group type: EXPERIMENTAL
Intervention: Elagolix alone (300 mg twice daily)
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: Elagolix with 0.5 mg estradiol/0.1 mg norethindrone acetate
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: Elagolix with 1.0 mg estradiol/0.5 mg norethindrone acetate
Number of subjects: 571

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: Elagolix groups
Number of subjects: 571
Study: 26975346

Group type: EXPERIMENTAL
Intervention: 50,000 U oral cholecalciferol monthly (Group A)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: 50,000 U oral cholecalciferol bimonthly (Group B)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo (Group C)
Number of subjects: 210
Study: 24308540

Group type: EXPERIMENTAL
Intervention: Garlic (three garlic tablets orally, twice daily for 14 days)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (three placebo tablets orally, twice daily for 14 days)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Garlic
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 22137103

Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT) in postmenopausal women after six months
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Premenopausal women
Number of subjects: 35

Group type: COMPARATOR
Intervention: Postmenopausal women
Number of subjects: 35
Study: 19933753

Group type: EXPERIMENTAL
Intervention: Recombinant human GH (rhGH) 33-50 microg kg(‐1) day(‐1) for 14 days
Number of subjects: 0
Study: 20298324

Group type: EXPERIMENTAL
Intervention: Smoking cessation groups (SCG) offered to patients in the intervention group
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Smoking cessation groups (SCG)
Number of subjects: 223
Study: 16928534

Group type: EXPERIMENTAL
Intervention: Instillation of 120 mL autologous blood into the apical chest drain on the fifth postoperative day, with additional doses on days 7 and 9 if necessary
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Instillation of 120 mL autologous blood
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tube thoracostomy alone (control group)
Number of subjects: 20
Study: 12745096

Group type: EXPERIMENTAL
Intervention: STEAMI
Number of subjects: 654

Group type: COMPARATOR
Intervention: UAP/NSTEAMI
Number of subjects: 654
Study: 10960201

Group type: COMPARATOR
Intervention: 0.2% ropivacaine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine/2 microg/mL fentanyl
Number of subjects: 32
Study: 8842502

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 24
Study: 1498533

Group type: EXPERIMENTAL
Intervention: application-impulse stimulation treatment
Number of subjects: 184

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 184
Study: 6474383

Group type: EXPERIMENTAL
Intervention: Verapamil (4 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 8
Study: 31409541

Group type: EXPERIMENTAL
Intervention: Collaborative dementia care management (DCM)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 444
Study: 29744313

Group type: EXPERIMENTAL
Intervention: Psycho-education provided by trained health workers
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (no psycho-education)
Number of subjects: 113
Study: 27377519

Group type: EXPERIMENTAL
Intervention: Endoscopist-controlled wire guidance
Number of subjects: 216

Group type: COMPARATOR
Intervention: Assistant-controlled wire guidance
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Small sphincterotome (3.9Fr tip)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Standard sphincterotome (4.4Fr tip)
Number of subjects: 216
Study: 24980612

Group type: EXPERIMENTAL
Intervention: Oxytocin nasal spray (24 IU B.I.D for participants 16 years and over; 18 IU B.I.D for participants 13-15 years; increased to 40 IU B.I.D for participants 16 years and over; 32 IU B.I.D for participants 13-15 years)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 22497201

Group type: EXPERIMENTAL
Intervention: Helmeted male cyclists
Number of subjects: 587

Group type: COMPARATOR
Intervention: Nonhelmeted male cyclists
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: Helmeted female cyclists
Number of subjects: 587

Group type: COMPARATOR
Intervention: Nonhelmeted female cyclists
Number of subjects: 587
Study: 20818864

Group type: EXPERIMENTAL
Intervention: Compression-only CPR
Number of subjects: 1276

Group type: COMPARATOR
Intervention: Standard CPR
Number of subjects: 1276
Study: 17350803

Group type: EXPERIMENTAL
Intervention: Noodle soup with lemonade
Number of subjects: 13

Group type: COMPARATOR
Intervention: Noodle soup without lemonade
Number of subjects: 13

Group type: COMPARATOR
Intervention: Noodles
Number of subjects: 13

Group type: COMPARATOR
Intervention: Bread alone
Number of subjects: 13

Group type: COMPARATOR
Intervention: Bread with chamomile infusion sweetened with panela
Number of subjects: 13
Study: 15533703

Group type: EXPERIMENTAL
Intervention: Panic-relevant picture stimuli
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Acoustic startle stimuli
Number of subjects: 30

Group type: COMPARATOR
Intervention: Not applicable (healthy controls)
Number of subjects: 30
Study: 12120849

Group type: EXPERIMENTAL
Intervention: Peer-led sex education sessions delivered by trained Year 12 peer educators.
Number of subjects: 301
Study: 10594400

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg o.m. or b.d. for 1 month plus 500 mg clarithromycin (b.d.) and 200 mg furazolidone (b.d.) for 1 week
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg (not specified in the intervention but mentioned in results)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Omeprazole plus clarithromycin and furazolidone
Number of subjects: 40
Study: 7486869

Group type: EXPERIMENTAL
Intervention: deprenyl + Sinemet
Number of subjects: 101

Group type: COMPARATOR
Intervention: placebo-deprenyl + Sinemet
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: deprenyl + bromocriptine
Number of subjects: 101

Group type: COMPARATOR
Intervention: placebo-deprenyl + bromocriptine
Number of subjects: 101
Study: 2099197

Group type: EXPERIMENTAL
Intervention: Metronidazole 400 mg twice daily for seven days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triple tetracycline 300 mg twice daily for two weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for metronidazole
Number of subjects: 0
Study: 7425389

Group type: EXPERIMENTAL
Intervention: Theophylline (T)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Metaproterenol (M)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination of Metaproterenol (M) and Theophylline (T)
Number of subjects: 20
Study: 31914790

Group type: EXPERIMENTAL
Intervention: Patient navigation with contingency management
Number of subjects: 801

Group type: EXPERIMENTAL
Intervention: Patient navigation without contingency management
Number of subjects: 801

Group type: COMPARATOR
Intervention: Control group (no patient navigation)
Number of subjects: 801

Group type: EXPERIMENTAL
Intervention: Early linkage to care
Number of subjects: 801
Study: 30968336

Group type: EXPERIMENTAL
Intervention: TA‐ER 32 mg
Number of subjects: 170

Group type: COMPARATOR
Intervention: Saline-placebo
Number of subjects: 170

Group type: COMPARATOR
Intervention: TAcs 40 mg
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 170
Study: 27884686

Group type: EXPERIMENTAL
Intervention: Group A: 10 mL lidocaine 1% (100 mg) mixed with polyvinyl alcohol particles (355‐500 μm)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group B: 10 mL lidocaine 1% (100 mg) injected after embolization
Number of subjects: 60

Group type: COMPARATOR
Intervention: Group C: Control group
Number of subjects: 60
Study: 25884195

Group type: EXPERIMENTAL
Intervention: Interactive gender-adapted prevention program in schools (6 school hours, includes educational elements about eating disorders, media influences, self-esteem, body perception)
Number of subjects: 1848

Group type: EXPERIMENTAL
Intervention: Intervention group evaluation of program components
Number of subjects: 1848
Study: 24084344

Group type: EXPERIMENTAL
Intervention: Occupational exposure to polycyclic aromatic hydrocarbons
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gene polymorphisms (CYP1A1, CYP1B1, EPHX1, GSTM1, GSTT1, GSTP1)
Number of subjects: 0
Study: 21820130

Group type: EXPERIMENTAL
Intervention: Vitamin D 5600 IU/week
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Vitamin D 11200 IU/week
Number of subjects: 54

Group type: COMPARATOR
Intervention: No supplementation (control group)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Vitamin D 800 IU/day
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Vitamin D 1600 IU/day
Number of subjects: 54
Study: 19730391

Group type: EXPERIMENTAL
Intervention: Amlodipine (5 or 10 mg/d) + Olmesartan medoxomil (10, 20, or 40 mg/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amlodipine + Olmesartan combinations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amlodipine monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Olmesartan monotherapy
Number of subjects: 0
Study: 17467884

Group type: EXPERIMENTAL
Intervention: TachoSil
Number of subjects: 185

Group type: COMPARATOR
Intervention: Standard suturing
Number of subjects: 185
Study: 15479842

Group type: EXPERIMENTAL
Intervention: HIV-1 variants with amino acid insertions (TGNS, SQVN, AQQA, SRPE, APP, PTAPPA) near Gag cleavage sites
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wild-type HIV-1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mutant protease
Number of subjects: 0
Study: 11906576

Group type: EXPERIMENTAL
Intervention: Pre‐incubation of the feed with lactase
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 53
Study: 9142381

Group type: EXPERIMENTAL
Intervention: LUAE + Apl
Number of subjects: 54
Study: 8424290

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Neurolept anaesthesia (NLA)
Number of subjects: 40
Study: 3688150

Group type: EXPERIMENTAL
Intervention: Group occupational therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 29027329

Group type: EXPERIMENTAL
Intervention: ivabradine
Number of subjects: 6505

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 6505
Study: 27647662

Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D deficiency
Number of subjects: 3181

Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D levels
Number of subjects: 3181
Study: 24076297

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg/day for 5 days (n = 1498)
Number of subjects: 2998
Study: 23768702

Group type: EXPERIMENTAL
Intervention: rabeprazole 20mg bid (RAC group, n=222)
Number of subjects: 426

Group type: COMPARATOR
Intervention: lansoprazole 30mg bid (LAC group, n=228)
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: rabeprazole 20mg bid (RAC group)
Number of subjects: 426

Group type: COMPARATOR
Intervention: lansoprazole 30mg bid (LAC group)
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: NSAID users
Number of subjects: 426

Group type: COMPARATOR
Intervention: Non-NSAID users
Number of subjects: 426
Study: 20228710

Group type: EXPERIMENTAL
Intervention: Nonsurgical treatment for HD
Number of subjects: 19

Group type: COMPARATOR
Intervention: Surgical treatment for HD
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: LSS studies
Number of subjects: 19
Study: 18635304

Group type: EXPERIMENTAL
Intervention: 6% hydrogen peroxide whitening strips
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo strips
Number of subjects: 80
Study: 16639664

Group type: EXPERIMENTAL
Intervention: Ultrasound evaluation of upper lid tarsus curvature in patients with paralytic lagophthalmos
Number of subjects: 97

Group type: COMPARATOR
Intervention: Ultrasound evaluation of upper lid tarsus curvature in healthy subjects
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Ultrasound evaluation of upper lid tarsus curvature in both groups
Number of subjects: 97
Study: 12721773

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin formulations stored under class IV conditions (40 degrees C, 75% relative humidity)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diclo 50 (Camden) and Dicloflame 50 (Intas) formulations stored under class IV conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ciprofloxacin formulations stored at ambient conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diclo 50 (Camden) and Dicloflame 50 (Intas) formulations stored at ambient conditions
Number of subjects: 0
Study: 11493735

Group type: EXPERIMENTAL
Intervention: WBC-reduced RBC units
Number of subjects: 1869
Study: 9230725

Group type: EXPERIMENTAL
Intervention: Regular anthelminthic treatment with albendazole for 1 year
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (asthmatic subjects without controlled parasitic infections)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regular anthelminthic treatment with albendazole
Number of subjects: 0
Study: 7495013

Group type: EXPERIMENTAL
Intervention: Triathletes
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-triathlete controls
Number of subjects: 30
Study: 3629189

Group type: EXPERIMENTAL
Intervention: Graded fundic distension with a balloon to 150 ml
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Graded fundic distension with a balloon to 300 ml
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Graded fundic distension with a balloon to 600 ml
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Continuous fundic distension with a volume of 300 ml for 2 1/2 h
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Anticholinergic drug benzilonium bromide during 30 min of fundic distension to 150 ml
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Indomethacin during fundic distension
Number of subjects: 13
Study: 29351007

Group type: EXPERIMENTAL
Intervention: Early renal replacement therapy (RRT) initiation strategy
Number of subjects: 619

Group type: EXPERIMENTAL
Intervention: Delayed renal replacement therapy (RRT) initiation strategy
Number of subjects: 619
Study: 28103388

Group type: EXPERIMENTAL
Intervention: Retinol (0.1%)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Retinyl propionate (0.5%)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Climbazole (0.5%)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Low-dose retinol (0.02%) + Climbazole (0.5%)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Retinol (0.02%) + Climbazole (0.5%)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Retinyl palmitate
Number of subjects: 16

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 16
Study: 26133126

Group type: EXPERIMENTAL
Intervention: Heavier growth chart (Chart A, n = 686)
Number of subjects: 1295

Group type: COMPARATOR
Intervention: Lighter growth chart (Chart B, n = 609)
Number of subjects: 1295

Group type: EXPERIMENTAL
Intervention: Both growth charts
Number of subjects: 1295
Study: 23039968

Group type: EXPERIMENTAL
Intervention: Home-based intensive counselling group (HBICG)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Facility-based semi-intensive counselling group (FBSICG)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 360
Study: 21570513

Group type: EXPERIMENTAL
Intervention: Enoxaparin (enox)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abciximab (abx)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abciximab (abx) combination therapy
Number of subjects: 0
Study: 18285668

Group type: EXPERIMENTAL
Intervention: Oseltamivir treatment for influenza A
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Oseltamivir treatment for influenza B
Number of subjects: 299

Group type: COMPARATOR
Intervention: Non-treated group for influenza A
Number of subjects: 299

Group type: COMPARATOR
Intervention: Non-treated group for influenza B
Number of subjects: 299
Study: 16866816

Group type: EXPERIMENTAL
Intervention: Infant massage
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Observation and modelling of behaviour with infant
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Kangaroo care
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Participation with child in a preschool programme
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Discussion groups
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Parent training programmes
Number of subjects: 12
Study: 12967058

Group type: EXPERIMENTAL
Intervention: Folic acid 10 mg/day
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 11034112

Group type: EXPERIMENTAL
Intervention: Oral melatonin (1 mg)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 9365082

Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Piroxicam
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ketoprofen or Piroxicam (responders)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ketoprofen or Piroxicam (RA patients)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ketoprofen or Piroxicam (both RA and OA patients)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Baseline ESR and white blood cell counts (RA patients)
Number of subjects: 20
Study: 31970414

Group type: EXPERIMENTAL
Intervention: HDAC8 inhibitor
Number of subjects: 0

Group type: COMPARATOR
Intervention: TGF‐β signaling
Number of subjects: 0
Study: 30500133

Group type: EXPERIMENTAL
Intervention: Cook media
Number of subjects: 120

Group type: COMPARATOR
Intervention: Vitrolife media
Number of subjects: 120
Study: 28849629

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 195

Group type: COMPARATOR
Intervention: Thiazide diuretics
Number of subjects: 195
Study: 26304075

Group type: EXPERIMENTAL
Intervention: Anagrelide
Number of subjects: 222

Group type: COMPARATOR
Intervention: Hydroxyurea
Number of subjects: 222
Study: 23617136

Group type: EXPERIMENTAL
Intervention: Osteopathy intervention (3 weeks, 3 times per week)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Traction intervention (3 weeks, 3 times per week)
Number of subjects: 187
Study: 21211891

Group type: EXPERIMENTAL
Intervention: Open treatment (Class 2b)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Closed treatment (Class 2a)
Number of subjects: 80
Study: 19370950

Group type: EXPERIMENTAL
Intervention: Doxofylline (400mg twice daily)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Slow release theophylline (400mg once a day at evening)
Number of subjects: 75
Study: 15948682

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) combined with porous hydroxyapatite (HA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: HA with saline (Control)
Number of subjects: 70
Study: 12360456

Group type: EXPERIMENTAL
Intervention: Alosetron (1-4 mg twice daily)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 10486645

Group type: EXPERIMENTAL
Intervention: Caucasian women (CC)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Caribbean women (CB)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 42
Study: 8735683

Group type: EXPERIMENTAL
Intervention: Ethinyloestradiol 50 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone 10 mg
Number of subjects: 8
Study: 1748539

Group type: EXPERIMENTAL
Intervention: labetalol (400 mg to 600 mg per day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 30
Study: 7097423

Group type: EXPERIMENTAL
Intervention: Pooled human milk (true protein 0.8 gm/dl)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Adapted or nonadapted milk formula (protein 1.5 gm/dl)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Pooled human milk and adapted or nonadapted milk formula
Number of subjects: 31
Study: 31990350

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 167
Study: 31881066

Group type: EXPERIMENTAL
Intervention: Randomized exercise variation (EXP)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Fixed exercise selection (CON)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both EXP and CON
Number of subjects: 21

Group type: COMPARATOR
Intervention: CON
Number of subjects: 21
Study: 28088243

Group type: EXPERIMENTAL
Intervention: Educational workshop addressing sedentary time and diabetes risk
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 71
Study: 26798966

Group type: EXPERIMENTAL
Intervention: LY900009 at 30 mg
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: LY900009 at 15 mg
Number of subjects: 35
Study: 24687576

Group type: EXPERIMENTAL
Intervention: Pre-warmed intravenous fluids (approximately 41 °C)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Room temperature intravenous fluids
Number of subjects: 53
Study: 22088795

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management (CBSM) intervention for 10 weeks
Number of subjects: 199

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 199
Study: 19320679

Group type: EXPERIMENTAL
Intervention: Immediate postal treatment for 3 months
Number of subjects: 204

Group type: COMPARATOR
Intervention: Delayed postal treatment (months 3-6)
Number of subjects: 204
Study: 17327244

Group type: EXPERIMENTAL
Intervention: Retention strategies implemented in a community-based HIV/STI prevention trial
Number of subjects: 0
Study: 15374763

Group type: EXPERIMENTAL
Intervention: Spoken dialogue modality
Number of subjects: 48

Group type: COMPARATOR
Intervention: Written dialogue modality
Number of subjects: 48
Study: 11150109

Group type: EXPERIMENTAL
Intervention: Fludrocortisone acetate, titrated to 0.1 mg/d (n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (n = 50)
Number of subjects: 100